Patents by Inventor Catherine To

Catherine To has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140034835
    Abstract: An optical filtering structure comprising a stack of layers forming a first filter letting pass a first spectral band, and a second filter adjacent to the first filter and which lets pass a second spectral band comprising: a plurality of dielectric layers common to the two filters and of different refractive indices; n first metal layers common to the two filters; m second metal layers arranged only in the second filter; and wherein at least one of said dielectric layers comprises, in the first filter, a thickness different to that in the second filter, and/or wherein at least one dielectric layer is arranged only in the second filter; n being an integer greater than or equal to 0, and m being an integer greater than or equal to 1.
    Type: Application
    Filed: July 25, 2013
    Publication date: February 6, 2014
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT
    Inventors: Laurent FREY, Marilyn Armand, Catherine Pelle
  • Publication number: 20140034823
    Abstract: An inert (non-radioactive) tagging material can be added to cement in a wellbore. The non-radioactive tagging material can emit radiation at a specific energy level when irradiated with radiation. A logging tool containing a radiation source can be introduced into a wellbore and activated to emit radiation. The logging tool can detect the radiation emitted from the non-radioactive tags within the wellbore. Accordingly, integrity of cement, particularly low density cements that have a density close to that of fluid provided to or contained within a hydrocarbon-bearing formation, can be determined from the detected radiation.
    Type: Application
    Filed: July 17, 2013
    Publication date: February 6, 2014
    Applicant: BP CORPORATION NORTH AMERICA INC.
    Inventor: Catherine Hyde-Barber
  • Publication number: 20140033399
    Abstract: A device to hold a garment in place, particularly the event of a gust of air, comprising an attachment member, a connecting member, and a weight, which can be worn either on the inside or outside surface of the garment. In operation the device attaches to a garment and pulls the garment vertically in accordance with gravity.
    Type: Application
    Filed: March 8, 2013
    Publication date: February 6, 2014
    Inventor: Catherine Jones
  • Publication number: 20140040072
    Abstract: A method, apparatus and computer program product are provided for allowing multiple users to view and exchange real estate data in real time. In the context of a method, a method is provided that includes causing an invitation to connect with an agent account to be transmitted form an agent device associated with the agent account to a client device associated with a client account. The method further includes receiving an indication of acceptance of the invitation from the client device and, in response, establishing an agent-client connection between the agent account and the client account, the agent-client connection allows information regarding real estate to be shared between an agent and a client via a customized user interface of a respective one of the agent device or the client device.
    Type: Application
    Filed: August 1, 2012
    Publication date: February 6, 2014
    Applicant: MOVE, INC.
    Inventors: Michael James Leavy, Alan Kerry Lewis, Catherine Elizabeth Tiritoglu, Cameron Thomas Bigger, Susan Eliot Briggs, Kurtis Derry
  • Patent number: 8642773
    Abstract: The present invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, including all stereoisomers and tautomers, which is an inhibitor of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha and gamma kinase sub-types thereof, and its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: February 4, 2014
    Assignee: Respivert Ltd.
    Inventors: Kazuhiro Ito, Peter Strong, William Garth Rapeport, Peter John Murray, John King-Underwood, Jonathan Gareth Williams, Stuart Onions, Catherine Elisabeth Charron
  • Patent number: 8642652
    Abstract: Esters of 2-propylheptanol with linear or branched, saturated or unsaturated C5-C36 carboxylic acids and C4-C36 dicarboxylic acids, compositions comprising these esters, and to the use of esters of 2-propylheptanol with linear or branched, saturated or unsaturated C5-C36-carboxylic acids and/or C4-C36-dicarboxylic acids in cosmetic and/or topical pharmaceutical preparations.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: February 4, 2014
    Assignee: Cognis IP Management GmbH
    Inventors: Markus Dierker, Catherine Weichold, Stefanie Althaus, Lars Zander, Daniela Prinz
  • Patent number: 8642731
    Abstract: The present invention relates to isolated Porphyromonas gingivalis polypeptides and nucleotides. The polypeptides include an amino acid sequence selected from the group consisting of: SEQ. ID. NO. 110; SEQ. ID. NO. 111; SEQ. ID. NO. 112; SEQ. ID. NO. 113; SEQ ID NO: 120; SEQ. ID. NO. 123; SEQ. ID. NO. 124; SEQ. ID. NO. 125; SEQ. ID. NO. 130; SEQ. ID. NO. 131; SEQ. ID. NO. 132; SEQ. ID. NO. 133; SEQ. ID. NO. 135; SEQ. ID. NO. 136; SEQ. ID. NO. 137; SEQ. ID. NO. 138; SEQ. ID. NO. 143; SEQ. ID. NO. 144; SEQ. ID. NO. 145; SEQ. ID. NO. 146; SEQ. ID. NO. 147; SEQ. ID. NO. 148; and amino acid sequences at least 95% identical thereto.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: February 4, 2014
    Assignees: CSL Limited, The University of Melbourne
    Inventors: Bruce C. Ross, Ian G. Barr, Michelle A. Patterson, Catherine T. Agius, Linda J. Rothel, Mai B. Margetts, Dianna M. Hocking, Elizabeth A. Webb
  • Patent number: 8642729
    Abstract: The present invention relates to modified opiorphin peptides as new inhibitors of metallo-ectopeptidases.
    Type: Grant
    Filed: April 7, 2009
    Date of Patent: February 4, 2014
    Assignee: Institut Pasteur
    Inventor: Catherine Rougeot
  • Patent number: 8644844
    Abstract: Methods and systems for indoor mobile unit positioning, for seamlessly toggling a mobile unit positioning between outdoor positioning and indoor positioning and for providing location based services or application generated by an external location server to the mobile unit while the mobile unit is indoors. The indoor mobile unit positioning includes mobile unit-based positioning which makes use of reception of access point signals by the mobile unit.
    Type: Grant
    Filed: December 21, 2008
    Date of Patent: February 4, 2014
    Assignee: Corning MobileAccess Ltd.
    Inventors: Isaac Shapira, Yair Shapira, Catherine Zatloukal
  • Patent number: 8642009
    Abstract: Methods and compositions are provided for the analysis of skin surfaces to determine the presence of neoplastic tissue. In the methods of the invention, a composition comprising a florescent probe that binds to a specific neoplasia associated marker is applied topically to the area of interest. After topical administration, the probe preferentially binds to markers associated in neoplastic lesions in situ, which binding is detected with a compact illumination unit that provides illumination at a wavelength appropriate for image acquisition. The illumination unit comprises a light source and fiber optic bundle to direct the light towards the area of examination. A detection unit is used to capture and record an image of the area of investigation. The detection unit may be a digital camera, film camera, etc. A mapping module may also be provided to catalogue the site of examination.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: February 4, 2014
    Inventors: Catherine M. Shachaf, Amit Shachaf
  • Publication number: 20140026714
    Abstract: A continuous flow reactor for nanoparticle synthesis comprises a modular system including a plurality of interconnected tubular components for fluid flow therethrough including a first tubular inlet and a second tubular inlet connected to a three-way junction comprising a tubular mixer. A continuous flow method for nanoparticle synthesis comprises flowing a growth solution and a reaction-initiating solution into a mixing portion of a flow reactor to form a mixed solution; flowing the mixed solution through a holding portion of the flow reactor for a predetermined residence time to form a reacted solution comprising nanoparticles; and continuously removing the reacted solution from the flow reactor so as to achieve a throughput of nanoparticles of at least about 0.5 mg/min.
    Type: Application
    Filed: July 25, 2013
    Publication date: January 30, 2014
    Applicant: The Board of Trustees of the University of Illinois
    Inventors: Catherine J. Murphy, Samuel E. Lohse, Jonathan R. Eller
  • Publication number: 20140029711
    Abstract: Apparatus for passively generating electric power during a nuclear power station blackout by utilizing the temperature difference between the hot inlet of a residual heat removal circuit and the surrounding containment environment. A heat engine, such as a thermoelectric generator, a Sterling Cycle Engine or Rankine Cycle Engine, is coupled in heat exchange relationship with an uninsulated portion of the inlet to a passive residual heat removal heat exchanger and/or passive residual heat removal heat exchanger channel head to generate the power required to operate essential equipment needed to maintain the nuclear power station in a safe condition during a loss of normal onsite and offsite power.
    Type: Application
    Filed: February 12, 2013
    Publication date: January 30, 2014
    Applicant: Westinghouse Electric Company LLC
    Inventors: Jeffrey T. Dederer, Catherine M. Perego
  • Publication number: 20140031231
    Abstract: New formulations of clomazone are provided, as well as new methods for making formulations of clomazone. The new formulations provide improved efficacy, decreased volatility, and/or increased loading of clomazone over the clomazone formulations in the prior art.
    Type: Application
    Filed: June 18, 2013
    Publication date: January 30, 2014
    Inventors: Hong Liu, Michael R. Welch, Paul Nicholson, Jeffrey A. Cook, Catherine Ranin, Sandra L. Shinn, Robert F. Pepper
  • Publication number: 20140031350
    Abstract: The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.
    Type: Application
    Filed: September 26, 2013
    Publication date: January 30, 2014
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Rajinder Singh, Ankush Argade, Donald Payan, Susan Molineaux, Sacha Holland, Jeffrey Clough, Holger Keim, Somasekhar Bhamidipati, Catherine Sylvain, Hui Li, Alexander Rossi
  • Publication number: 20140030966
    Abstract: A process is provided for polishing a silicon electrode utilizing a polishing turntable and a dual function electrode platen secured to the polishing, which can comprise a plurality of electrode mounts arranged to project from an electrode engaging face of the dual function electrode platen. The electrode mounts and mount receptacles can be configured to permit non-destructive engagement and disengagement of the electrode engaging face of the electrode platen and the platen engaging face of the silicon electrode. The silicon electrode can be polished by (i) engaging the electrode engaging face of the electrode platen and the platen engaging face of the silicon electrode via the electrode mounts and mount receptacles, (ii) utilizing the polishing turntable to impart rotary, and (iii) contacting an exposed face of the silicon electrode with a polishing surface as the silicon electrode. Additional embodiments are contemplated, disclosed and claimed.
    Type: Application
    Filed: September 9, 2013
    Publication date: January 30, 2014
    Applicant: Lam Research Corporation
    Inventors: Armen Avoyan, Duane Outka, Catherine Zhou, Hong Shih
  • Publication number: 20140030248
    Abstract: Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
    Type: Application
    Filed: April 16, 2013
    Publication date: January 30, 2014
    Applicant: Allergan, Inc.
    Inventors: Catherine C. Turkel, Sheena K. Aurora, Mitchell F. Brin
  • Publication number: 20140032725
    Abstract: Computer-based methods and systems for deploying model-driven applications to an application server are described. Consistent with an embodiment of the invention, an application server includes a model deployment module that provides a model deployment service. The model deployment module receives as input a data model that serves as a single source of truth for an application. Based on the input model, the model deployment module configures the application server, for example, by automatically generating object-relational mapping logic that facilitates data persistence by mapping data elements in an object domain to data elements in a relational database domain. Additionally, the model deployment module generates a utility module that supports advanced modeling capabilities, including derived properties and constraints.
    Type: Application
    Filed: August 28, 2009
    Publication date: January 30, 2014
    Applicant: Adobe Systems Incorporated
    Inventors: Edward Solovey, Catherine G. Reilly, Thomas Jordahl, Basil C. Hosmer, Svetlin Kalaydjiev
  • Publication number: 20140029712
    Abstract: Example embodiments relate to a method and apparatus for reducing electrostatic deposition of charged particles on wetted surfaces that are exposed, periodically or substantially continuously, to high velocity fluid flow within a coolant flow path in a nuclear reactor. The method may include depositing a first or base dielectric layer and a second or outer dielectric layer on a conductive surface that forms a portion of a high velocity flow path to attain the apparatus. The first dielectric layer material is selected to provide improved adhesion and insulation to the conductive surface and the second dielectric layer material is selected to provide suitable adhesion to the first dielectric layer and improved corrosion and/or mechanical resistance in the anticipated operating environment.
    Type: Application
    Filed: September 16, 2011
    Publication date: January 30, 2014
    Inventors: Catherine Procik DULKA, Young Jin Kim, Rajasingh Schwartz Israel, David Wesley Sandusky, Kevin H. Janora, Peter W. Brown, Tianji Zhao
  • Publication number: 20140031659
    Abstract: A bleeding detection unit in a surgical system processes information in an acquired scene before that scene is presented on a display unit in the operating room. For example, the bleeding detection unit analyzes the pixel data in the acquired scene and determines whether there are one or more initial sites of blood in the scene. Upon detection of an initial site of blood, the region is identified by an initial site icon in the scene displayed on the display unit. In one aspect, the processing is done in real-time which means that there is no substantial delay in presenting the acquired scene to the surgeon.
    Type: Application
    Filed: July 22, 2013
    Publication date: January 30, 2014
    Applicant: Intuitive Surgical Operations, Inc.
    Inventors: Wenyi ZHAO, Catherine J. Mohr, Jonthan M. Sorger
  • Publication number: 20140030285
    Abstract: Provided herein are OspA polypeptides from Lyme Disease-causing Borrelia having certain alteration(s). In one embodiment, the alteration(s) increase the conformational stability of the OspA polypeptide containing the alteration(s) while maintaining at least some of the antigenicity of the corresponding unaltered OspA polypeptide. In another embodiment, the altered OspA polypeptide has reduced cross-reactivity to hLFA-1, as compared to the corresponding unaltered OspA polypeptide.
    Type: Application
    Filed: July 17, 2013
    Publication date: January 30, 2014
    Applicants: Brookhaven Sciences Associates, LLC, Research Foundation of the State University of New York, University of Rochester
    Inventors: Benjamin J. Luft, John J. Dunn, Shohei Koide, Catherine L. Lawson